相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Multifaceted regulation of translation by the epitranscriptomic modification N6-methyadenosine
Xiao-Min Liu et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)
Biological functions of m6A methyltransferases
Jianzhong Gu et al.
CELL AND BIOSCIENCE (2021)
Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure
Ubaid Tariq et al.
CURRENT DRUG TARGETS (2021)
Remodeling of the m6A landscape in the heart reveals few conserved post-transcriptional events underlying cardiomyocyte hypertrophy
Scott A. Hinger et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)
What do Transcription Factors Interact With?
Haining Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Emerging Perspectives of RNA N6-methyladenosine (m6A) Modification on Immunity and Autoimmune Diseases
Lipeng Tang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Metabolic Control of m6A RNA Modification
Joohwan Kim et al.
METABOLITES (2021)
Epigenetics-based therapeutics for myocardial fibrosis
Xuping Li et al.
LIFE SCIENCES (2021)
Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics
Rongkai Shi et al.
CELL DEATH & DISEASE (2021)
The role of m6A modification in the biological functions and diseases
Xiulin Jiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling
Yanchun Zhao et al.
THERANOSTICS (2021)
Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants
Loredana Bury et al.
HUMAN MUTATION (2020)
Changes in m6A RNA methylation contribute to heart failure progression by modulating translation
Tea Berulava et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer
Haiyun Xie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy
Zongna Ren et al.
CIRCULATION (2020)
Risk Stratification in Hypertrophic Cardiomyopathy. Insights from Genetic Analysis and Cardiopulmonary Exercise Testing
Damiano Magri et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Structural and Dynamic Insights into Redundant Function of YTHDF Proteins
Yaozong Li et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology
Xinyu Fang et al.
GENES & DISEASES (2020)
FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair
Prabhu Mathiyalagan et al.
CIRCULATION (2019)
Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking
Joseph R. Goldenberg et al.
CIRCULATION (2019)
m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response
Ruiqing Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study
Clare J. Taylor et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Effects of the loss of estrogen on the heart's hypertrophic response to chronic left ventricle volume overload in rats
Elisabeth Walsh-Wilkinson et al.
PEERJ (2019)
The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy
Lisa E. Dorn et al.
CIRCULATION (2019)
Atrial and Brain Natriuretic Peptides- Benefits and Limits of their use in Cardiovascular Diseases
Mustafa Edme Roxana et al.
CURRENT CARDIOLOGY REVIEWS (2019)
Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner
Ruifan Wu et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy Results From the International Sarcomeric Human Cardiomyopathy Registry
Seung-Pyo Lee et al.
CIRCULATION-HEART FAILURE (2018)
YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA
Hailing Shi et al.
CELL RESEARCH (2017)
Polysome Fractionation to Analyze mRNA Distribution Profiles
Amaresh C. Panda et al.
BIO-PROTOCOL (2017)
YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex
Hao Du et al.
NATURE COMMUNICATIONS (2016)
Epigenetics in heart failure phenotypes
Alexander Berezin
BBA CLINICAL (2016)
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Xiao Wang et al.
CELL (2015)
Structural Implications of β-Cardiac Myosin Heavy Chain Mutations in Human Disease
Melanie Colegrave et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2014)
Inhibition of Cardiomyocyte Hypertrophy by Protein Arginine Methyltransferase 5
Ming Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
Cellular mechanisms of cardiomyopathy
Pamela A. Harvey et al.
JOURNAL OF CELL BIOLOGY (2011)
Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes
Adam B. Stein et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Global quantification of mammalian gene expression control
Bjoern Schwanhaeusser et al.
NATURE (2011)
Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark
Alexander J. Ruthenburg et al.
MOLECULAR CELL (2007)
Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan
JW Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Analysis of myosin heavy chain functionality in the heart
M Krenz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)